Nicholas Hoffman & Company’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Buy
1,007
+7
+0.7% +$2.96K 0.01% 264
2026
Q1
$473K Hold
1,000
0.01% 231
2025
Q4
$467K Hold
1,000
0.01% 226
2025
Q3
$426K Hold
1,000
0.01% 239
2025
Q2
$383K Hold
1,000
0.01% 238
2025
Q1
$346K Hold
1,000
0.01% 233
2024
Q4
$300K Hold
1,000
0.01% 239
2024
Q3
$406K Hold
1,000
0.02% 222
2024
Q2
$321K Hold
1,000
0.02% 234
2024
Q1
$334K Hold
1,000
0.02% 227
2023
Q4
$271K Hold
1,000
0.02% 242
2023
Q3
$246K Hold
1,000
0.02% 237
2023
Q2
$303K Hold
1,000
0.01% 214
2023
Q1
$264K Hold
1,000
0.02% 238
2022
Q4
$240K Buy
+1,000
New +$224K 0.03% 238
2022
Q2
Sell
-1,000
Closed -$251K 273
2022
Q1
$251K Hold
1,000
0.01% 251
2021
Q4
$257K Hold
1,000
0.01% 244
2021
Q3
$243K Hold
1,000
0.04% 238
2021
Q2
$207K Buy
+1,000
New +$204K 0.04% 256

Other funds holding HCA

Nicholas Hoffman & Company's HCA Position: Q2 2026 in Review

Nicholas Hoffman & Company increased its HCA Healthcare (HCA) stake by 0.7% in Q2 2026, buying an estimated $2.96K and bringing the position to 1,007 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #264.

Nicholas Hoffman & Company first reported a position in HCA in Q2 2021 and has held it in 19 quarters since. The position peaked at $473K in Q1 2026. 750 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Nicholas Hoffman & Company held 1,007 shares of HCA Healthcare worth $393K as of Q2 2026.
  • Nicholas Hoffman & Company bought 7 HCA Healthcare shares in Q2 2026, an estimated $2.96K.
  • HCA Healthcare made up 0.01% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #264 holding.
  • Nicholas Hoffman & Company first reported a position in HCA Healthcare in Q2 2021 and has held it in 19 quarters since.
  • Nicholas Hoffman & Company's HCA Healthcare position peaked at $473K in Q1 2026.
  • 750 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.